BioCentury
ARTICLE | Financial News

Editas raises $50M follow-on

December 7, 2017 12:10 AM UTC

Gene editing company Editas Medicine Inc. (NASDAQ:EDIT) said it raised about $50 million through the sale of 1.97 million shares in a follow-on underwritten by Morgan Stanley. Editas did not respond to an inquiry regarding the exact price.

Editas, which proposed the offering after market close Tuesday, lost $2.12 to $25.17 on Wednesday...

BCIQ Company Profiles

Editas Medicine Inc.